Abstract:BACKGROUND Aldosterone has been implicated in a variety of organ fibroses, but its role and mechanism in liver fibrosis remain unclear. METHODS Rat primary hepatic stellate cells (HSCs) were isolated, cultured, and characterized. HSCs were incubated with aldosterone (10(-6) M) for 4 h, 8 h, 12 h, 24 h, and 48 h, after which TGF-β1 (transforming growth factor beta 1) expression was measured by real-time PCR. Rat HSCs were treated with different concentrations of aldosterone (10(-6) M, 10(-7) M, 10(-8) M, and 10(-9) M), and the expressions of PAI-1 (plasminogen activator inhibitor-1) and TGF-β1 were determined by measuring mRNA and protein. HSCs were incubated in groups containing aldosterone (10(-6) M), spironolactone (10(-5) M), both aldosterone and spironolactone, or neither aldosterone nor spironolactone (control), after which mRNA and protein expression of PAI-1 and TGF-β1 were measured. Collagen I expression was detected by immunohistochemical analysis of supernatants of the aldosterone (10(-6) M), TGF-β1, and aldosterone plus TGF-β1 groups. SMAD expression was detected in rat HSC control, HSC plus aldosterone (10(-6) M), HSC plus TGF-β1, and HSC plus aldosterone plus TGF-β1 groups. RESULTS HSCs were incubated with aldosterone for 4 h, 8 h, 12 h, 24 h, and 48 h after which TGF-β1 expression was measured. We found that TGF-β1 expression increased in a time dependent manner and reached a peak at 24 h. The expression of TGF-β1 in groups treated with aldosterone for 4 h, 8 h, 12 h, and 24 h was significantly different from the control group (P < 0.01). No significant difference was seen in TGF-β1 expression between the groups treated with aldosterone for 24 h and 48 h (P > 0.05). Compared with the control group, TGF-β1 expression was significantly increased after incubation with different concentrations of aldosterone (10(-6) M, 10(-7) M, 10(-8) M, and 10(-9) M) (P < 0.01). There were significant differences in the expression of TGF-β1 between 10(-6) M and 10(-7) M aldosterone treatment groups (P < 0.01). Compared with the control group, the expression of PAI-1 was significantly increased after incubation with different concentrations of aldosterone (10(-6) M, 10(-7) M, 10(-8) M, and 10(-9) M) (P < 0.01). PAI-1 expression was increased in the aldosterone, spironolactone, and aldosterone plus spironolactone groups. The expression of PAI-1 was significantly enhanced in the aldosterone and aldosterone plus spironolactone groups compared with the control group (P < 0.01). There was a marked enhancement of collagen I expression in the aldosterone, TGF-β1, and aldosterone plus TGF-β1 groups (P < 0.05). Collagen I expressions in the aldosterone and TGF-β1 groups were significantly different from the aldosterone plus TGF-β1 group (P < 0.01). Compared with the control group, SMAD expression was markedly elevated in the aldosterone, TGF-β1, and aldosterone plus TGF-β1 groups (P < 0.05). The expression of SMAD was significantly increased in the aldosterone plus TGF-β1 group compared with the aldosterone group (P < 0.01). CONCLUSION This study demonstrated that aldosterone promoted HSC activation and the expression of TGF-β1, PAI-1, and collagen in hepatic fibrosis progression and that spironolactone administration partially reversed the effects. The aldosterone promotional effect on hepatic fibrosis was partially mediated by TGF-β1.

[Effect of Protein Kinase C/transforming Growth Factor Beta 1 Pathway on Activation of Hepatic Stellate Cells].

Effects of CaMKⅡ/ERK signal pathway on TGFβ1-induced human hepatic stellate cell proliferation

Ca2+/calmodulin‐ Dependent Protein Kinase II Mediates Transforming Growth Factor‐β‐induced Hepatic Stellate Cells Proliferation but Not in Collagen Α1(i) Production

Transforming Growth Factor-1 Downregulation of Smad 1 Gene Expression in Rat Hepatic Stellate Cells

Effects of angiotensin Ⅱ on protein kinase Cε and Cα expression in hepatic stellate cells

[Effect of Beta-Catenin on the Activation of Hepatic Stellate Cells Induced by Transforming Growth Factor-Beta1].

Effect of Aldosterone and Its Antagonist on the Expression of PAI-1 and TGF-β1 in Rat Hepatic Stellate Cells.

[Regulation of Hepatic Stellate Cell Activation by Interleukin-10/Platelet Derived Growth Factor/mitogen-Activated Protein Kinase Pathway].

Effects of the Tyrosine Protein Kinase Inhibitor Genistein on the Proliferation, Activation of Cultured Rat Hepatic Stellate Cells.

Effect of collagens and growth factors (TGF β1, PDGF-BB) on cytoskeletal reorganization and cell migration in hepatic stellate cells

Effects of Rho GTPase expression and migration induced by transform growth factorβ1 in hepatic stellate cells

[The Effect of Ligand of Peroxisome Proliferators-Activated Receptor Gamma 15D-Pgj2 on the Proliferation and Activation of Hepatic Stellate Cells].

Effects of Ca~(2+)/calmodulin-dependent protein kinase Ⅱ on PDGF-induced collagen α1(Ⅰ) production in human hepatic stellate cells

TGF-β1 activates mouse hepatic stellate cells through Jagged1/Notch

Transforming growth factor-β1 induces mesenchymal-epithelial-transition of hepatic stellate cells

In Vitro Study on the Role and Mechanism of Interferon Α-1B in Regulating the Inhibition of Protein Kinase Cεand Cα on Fibrosis of Hepatic Stellate Cells

TGF-β1 Activated Hepatic Stellate Cells Induce Angiogenesis of Vascular Endothelial Cells

Hepatic Stellate Cells Regulate Hepatic Progenitor Cells Differentiation Via The Tgf-Beta 1/Jagged1 Signaling Axis

Ca2+/Calmodulin-Dependent Protein Kinase II Mediates Platelet-Derived Growth Factor-Induced Human Hepatic Stellate Cell Proliferation

Effects of Antisense Transforming Growth Factor Β Receptor-ⅰ Expressing Plasmid on Rat Activated Hepatic Stellate Cells in Vitro

Divergence of TGFβ Signaling in Activated Hepatic Stellate Cells Downstream from Smad2 Phosphorylation